Ken‐ichi Ogawara
- Molecular Biology top 10%
- Biomaterials top 1%
- Pharmaceutical Science top 0.2%
- Biomedical Engineering top 5%
- Oncology top 5%
- Co-authors
- Kazutaka HigakiToshikiro KimuraKentaro FurumotoYoshinobu TakakuraMitsuru HashidaToshiya KaiTamer M. ShehataKeita Un
- Topics
- Advanced Drug Delivery Systems (36 papers)Nanoparticle-Based Drug Delivery (32 papers)Drug Transport and Resistance Mechanisms (28 papers)
- Journals
- Biochemical and Biophysical Research CommunicationsJournal of Controlled ReleaseJournal of Pharmacology and Experimental Therapeutics
- Partner nations
- JapanNetherlandsEgypt
In The Last Decade
Ken‐ichi Ogawara
120 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 133
- Molecular Biology 1.0k
- Biomaterials 1.0k
- Pharmaceutical Science 885
- Biomedical Engineering 548
- Oncology 483
Countries citing papers authored by Ken‐ichi Ogawara
This map shows the geographic impact of Ken‐ichi Ogawara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken‐ichi Ogawara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken‐ichi Ogawara more than expected).
Fields of papers citing papers by Ken‐ichi Ogawara
This network shows the impact of papers produced by Ken‐ichi Ogawara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken‐ichi Ogawara. The network helps show where Ken‐ichi Ogawara may publish in the future.
Co-authorship network of co-authors of Ken‐ichi Ogawara
This figure shows the co-authorship network connecting the top 25 collaborators of Ken‐ichi Ogawara. A scholar is included among the top collaborators of Ken‐ichi Ogawara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken‐ichi Ogawara. Ken‐ichi Ogawara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 16 | |
| 5 | 10 | |
| 6 | 13 | |
| 7 | 3 | |
| 8 | 9 | |
| 9 | 5 | |
| 10 | 122 | |
| 11 | 13 | |
| 12 | 58 | |
| 13 | 21 | |
| 14 | 16 | |
| 15 | 21 | |
| 16 | 161 | |
| 17 | 18 | |
| 18 | 4 | |
| 19 | 111 | |
| 20 | 23 |
About Ken‐ichi Ogawara
Ken‐ichi Ogawara is a scholar working on Pharmaceutical Science, Biomaterials and Pharmacology, having authored 123 papers that have together received 3.0k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (36 papers), Nanoparticle-Based Drug Delivery (32 papers) and Drug Transport and Resistance Mechanisms (28 papers). The work is most often cited by research in Pharmaceutical Science (885 citations), Biomaterials (1.0k citations) and Pharmacology (163 citations). Ken‐ichi Ogawara has collaborated with scholars based in Japan, Netherlands and Egypt. Frequent co-authors include Kazutaka Higaki, Toshikiro Kimura, Toshikiro Kimura, Kentaro Furumoto, Yoshinobu Takakura, Mitsuru Hashida, Toshiya Kai, Tamer M. Shehata, Keita Un and Yusuke Kono. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Controlled Release and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.